Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Download All
Gain expert guidance on optimal use of biomarkers to guide treatment decisions for advanced NSCLC with this educational program featuring an on-demand webcast and downloadable slidesets from a live CCO webinar along with a podcast of the experts answering questions from the audience.
Jamie E. Chaft, MD
Stephen V. Liu, MD
Nathan Pennell, MD, PhD

Podcast

In this podcast episode, listen to lung cancer experts Nathan Pennell, MD, PhD; Jamie E. Chaft, MD; and Stephen V. Liu, MD, answer audience questions from a live CCO webinar on biomarker testing to guide selection of targeted and immune checkpoint inhibitor–based therapies for advanced NSCLC.

Jamie E. Chaft, MD Stephen V. Liu, MD Nathan Pennell, MD, PhD Released: May 19, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
Lilly
Regeneron Pharmaceuticals, Inc & Sanofi Genzyme

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue